Wedbush Upgrades Sutro Biopharma (STRO) to Outperform

May 15, 2026 6:34 AM

Wedbush analyst David Nierengarten upgraded Sutro Biopharma (NASDAQ: STRO) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found